ANTICANCER COMBINATION OF ARTEMISININ-BASED DRUGS AND OTHER CHEMOTHERAPEUTIC AGENTS

• 1. 青蒿素基药物与其他化学治疗剂的抗癌组合物 [P] . 中国专利： CN102665711A . 2012-09-12
• 2. 纳米脂质体载体组合物或者用于治疗由于KRAS基因突变而对抗癌药物具有抗性的结直肠癌的包含所述组合物的治疗剂 [P] . 中国专利： CN110325176A . 2019-10-11
• 3. "anticancer combinations of artemisinin-based drugs and other chemotherapeutic agents" [P] . BR112012015606A2 . 2018-05-29

  机译： “基于青蒿素的药物和其他化学治疗剂的抗癌组合”

• 4. Anticancer combination of artemisinin-based drugs and other chemotherapeutic agents [P] . 美国专利： US9023861B2 . 2015-05-05

  机译： 青蒿素类药物和其他化学治疗剂的抗癌组合

• 5. ANTICANCER COMBINATION OF ARTEMISININ-BASED DRUGS AND OTHER CHEMOTHERAPEUTIC AGENTS [P] . SG10201408485SA . 2015-01-29

  机译： 青蒿素类药物和其他化学治疗剂的抗癌药组合

• 1. Advances in drug delivery system for platinum agents based combination therapy [J] . Xiang Kang, Hai-Hua Xiao23, Hai-Qin Song45, 癌症生物学与医学：英文版 . 2015,第004期
• 2. Comparison of the synergistic anticancer activity of AlPcS4 photodynamic therapy in combination with different low-dose chemotherapeutic agents on gastric cancer cells [J] . Xin Jing, Wang Senhao, Zhang Luwei, Oncology reports . 2018,第1期
• 3. Clinical experience with drug delivery systems as tools to decrease the toxicity of anticancer chemotherapeutic agents [J] . Maranhao Raul C., Vital Carolina G., Tavoni Thauany M., Expert opinion on drug delivery . 2017,第7a12期
• 4. Synergistic anticancer activity of a novel oral chemotherapeutic agent containing trifluridine and tipiracil in combination with anti-PD-1 blockade in microsatellite stable-type murine colorectal cancer cells [J] . Norihiko Suzuki, Hiroshi Tsukihara, Fumio Nakagawa, American Journal of Cancer Research . 2017,第10期
• 5. Useful Combination Therapy of Anti-angiogenic Agent with Chemotherapeutic Agents or RadionuclideTherapy for Cancer Treatment [C] . Sun-Ju Choi, So-Young Lee, Young-Don Hong Controlled Release Society Annual Meeting and Exposition . 2007
• 6. Design and Synthesis of Pyrimidine Based Heterocycles as Potential Anti-cancer Agents with Combination Chemotherapeutic Potential or Targeted One Carbon Metabolism Inhibition and Anti-opportunistic Agents [D] . Doshi, Arpit. 2019
• 7. Comparison of the synergistic anticancer activity of AlPcS4 photodynamic therapy in combination with different low-dose chemotherapeutic agents on gastric cancer cells [O] . Jing Xin, Senhao Wang, Luwei Zhang, -1
• 8. Comparison of the synergistic anticancer activity of AlPcS4 photodynamic therapy in combination with different low‑dose chemotherapeutic agents on gastric cancer cells [O] . Jing Xin, Senhao Wang, Luwei Zhang, 2018

• 1. Improved Anticancer Effects on Various Cancers with Combinations of Chemotherapeutic Drugs or Vitamin C and D-Fraction [J] . Sensuke Konno ,Bobby Alexander ,Drew Freilich . 癌症治疗（英文） . 2013,第4期
• 2. Drug combination therapy:providing evidence of significant superiority of a combination of drugs compared to the single agents [J] . Xiong-Zhi Wu1 . TMR药物联合治疗 . 2019,第001期
• 3. Drug therapy: Solamargine and other solasodine rhamnosyl glycosides as anticancer agents [J] . Bill E. Cham . 化疗（英文） . 2013,第2期
• 4. Synergistic Anticancer Activity of Topotecan— Cyclin-Dependent Kinase Inhibitor Combinations against Drug-Resistant Small Cell Lung Cancer (SCLC) Cell Lines [J] . Gerhard Hamilton ,Ulrike Olszewski Lukas Klameth ,Ernst Ulsperger . 癌症治疗（英文） . 2013,第8期
• 5. 青蒿素类药物与血红素相互作用的电化学研究 [C] . 姜慧君 ,王凤彬 ,周家宏 . 第十一次全国电化学会议 . 2001
• 6. 暗罗素与青蒿素类药物联合使用对伯氏疟原虫青蒿素抗性鼠疟的疗效及相关免疫学机理研究 [A] . 杨叶鹏 . 2018